Arkema Resultados de beneficios anteriores
Pasado controles de criterios 1/6
Los beneficios de Arkema han disminuido a una tasa media anual de -1.2%, mientras que en la industria Chemicals los beneficios crecieron en un 7.4% anualmente. Los ingresos han ido creciendo a una tasa media de 4.3% al año. La rentabilidad financiera de Arkema es de 5%, y sus márgenes netos son de 3.6%.
Información clave
-1.2%
Tasa de crecimiento de los beneficios
-0.7%
Tasa de crecimiento del BPA
| Crecimiento de la industria Chemicals | 10.4% |
| Tasa de crecimiento de los ingresos | 4.3% |
| Rentabilidad financiera | 5.0% |
| Margen neto | 3.6% |
| Próxima actualización de resultados | 27 Feb 2025 |
Actualizaciones de resultados anteriores recientes
Recent updates
Arkema S.A. (EPA:AKE) Just Reported Third-Quarter Earnings: Have Analysts Changed Their Mind On The Stock?
Nov 09
Investors Can Find Comfort In Arkema's (EPA:AKE) Earnings Quality
Aug 08Results: Arkema S.A. Exceeded Expectations And The Consensus Has Updated Its Estimates
Aug 05We Think Arkema (EPA:AKE) Is Taking Some Risk With Its Debt
Jul 16Arkema's (EPA:AKE) Shareholders Will Receive A Bigger Dividend Than Last Year
May 13Arkema (EPA:AKE) Has Announced That It Will Be Increasing Its Dividend To €3.50
Apr 25Is Arkema (EPA:AKE) A Risky Investment?
Mar 29Arkema (EPA:AKE) Will Pay A Larger Dividend Than Last Year At €3.50
Mar 08Arkema S.A. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Mar 02Arkema (EPA:AKE) Has A Pretty Healthy Balance Sheet
Dec 30An Intrinsic Calculation For Arkema S.A. (EPA:AKE) Suggests It's 37% Undervalued
Dec 15Is It Time To Consider Buying Arkema S.A. (EPA:AKE)?
Nov 29Does Arkema (EPA:AKE) Have A Healthy Balance Sheet?
Sep 07Are Investors Undervaluing Arkema S.A. (EPA:AKE) By 44%?
Aug 20Is It Too Late To Consider Buying Arkema S.A. (EPA:AKE)?
Aug 02Arkema (EPA:AKE) Takes On Some Risk With Its Use Of Debt
May 28Arkema (EPA:AKE) Is Increasing Its Dividend To €3.40
May 13Are Investors Undervaluing Arkema S.A. (EPA:AKE) By 25%?
May 09Why Arkema S.A. (EPA:AKE) Could Be Worth Watching
Apr 24Arkema (EPA:AKE) Will Pay A Larger Dividend Than Last Year At €3.40
Apr 05Arkema's (EPA:AKE) Dividend Will Be Increased To €3.40
Feb 26Arkema (EPA:AKE) Has A Somewhat Strained Balance Sheet
Feb 14Are Investors Undervaluing Arkema S.A. (EPA:AKE) By 31%?
Jan 30Is It Time To Consider Buying Arkema S.A. (EPA:AKE)?
Jan 14Here's Why Arkema (EPA:AKE) Can Manage Its Debt Responsibly
Nov 02At €76.10, Is Arkema S.A. (EPA:AKE) Worth Looking At Closely?
Oct 11Arkema (EPA:AKE) Has A Pretty Healthy Balance Sheet
Jul 19What Is Arkema S.A.'s (EPA:AKE) Share Price Doing?
Jul 04If You Like EPS Growth Then Check Out Arkema (EPA:AKE) Before It's Too Late
Jun 03Arkema's (EPA:AKE) Upcoming Dividend Will Be Larger Than Last Year's
May 10Arkema (EPA:AKE) Is Increasing Its Dividend To €3.00
Apr 25Is There An Opportunity With Arkema S.A.'s (EPA:AKE) 47% Undervaluation?
Apr 24Arkema (EPA:AKE) Has Announced That It Will Be Increasing Its Dividend To €3.00
Apr 10Arkema (EPA:AKE) Is Increasing Its Dividend To €3.00
Mar 27Desglose de ingresos y gastos
Cómo gana y gasta dinero Arkema. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
|---|---|---|---|---|
| 30 Sep 24 | 9,493 | 346 | 926 | 255 |
| 30 Jun 24 | 9,425 | 342 | 913 | 276 |
| 31 Mar 24 | 9,331 | 349 | 898 | 274 |
| 31 Dec 23 | 9,514 | 402 | 892 | 275 |
| 30 Sep 23 | 9,799 | 393 | 870 | 275 |
| 30 Jun 23 | 10,445 | 503 | 875 | 273 |
| 31 Mar 23 | 11,187 | 752 | 870 | 274 |
| 31 Dec 22 | 11,550 | 949 | 858 | 270 |
| 30 Sep 22 | 11,543 | 1,050 | 863 | 264 |
| 30 Jun 22 | 10,969 | 1,073 | 836 | 257 |
| 31 Mar 22 | 10,180 | 1,498 | 815 | 248 |
| 31 Dec 21 | 9,519 | 1,293 | 788 | 243 |
| 30 Sep 21 | 9,004 | 1,212 | 768 | 242 |
| 30 Jun 21 | 8,515 | 1,057 | 755 | 240 |
| 31 Mar 21 | 8,022 | 350 | 739 | 238 |
| 31 Dec 20 | 7,884 | 304 | 755 | 241 |
| 30 Sep 20 | 7,952 | 312 | 796 | 242 |
| 30 Jun 20 | 8,259 | 365 | 815 | 246 |
| 31 Mar 20 | 8,611 | 422 | 828 | 251 |
| 31 Dec 19 | 8,738 | 491 | 812 | 249 |
| 30 Sep 19 | 8,892 | 561 | 782 | 245 |
| 30 Jun 19 | 8,843 | 590 | 766 | 242 |
| 31 Mar 19 | 8,859 | 633 | 761 | 239 |
| 31 Dec 18 | 8,816 | 674 | 758 | 237 |
| 30 Sep 18 | 8,566 | 685 | 749 | 235 |
| 30 Jun 18 | 8,418 | 653 | 743 | 232 |
| 31 Mar 18 | 8,346 | 594 | 736 | 234 |
| 31 Dec 17 | 8,326 | 543 | 738 | 235 |
| 30 Sep 17 | 8,221 | 492 | 733 | 233 |
| 30 Jun 17 | 8,040 | 446 | 728 | 231 |
| 31 Mar 17 | 7,794 | 433 | 722 | 227 |
| 31 Dec 16 | 7,535 | 394 | 705 | 222 |
| 30 Sep 16 | 7,443 | 390 | 701 | 220 |
| 30 Jun 16 | 7,551 | 355 | 701 | 218 |
| 31 Mar 16 | 7,705 | 341 | 693 | 214 |
| 31 Dec 15 | 7,683 | 285 | 677 | 209 |
| 30 Sep 15 | 7,354 | 263 | 616 | 194 |
| 30 Jun 15 | 6,886 | 226 | 555 | 181 |
| 31 Mar 15 | 6,300 | 144 | 493 | 168 |
| 31 Dec 14 | 5,952 | 167 | 442 | 155 |
| 30 Sep 14 | 5,932 | 161 | 430 | 148 |
| 30 Jun 14 | 5,949 | 202 | 426 | 145 |
| 31 Mar 14 | 6,058 | 275 | 424 | 143 |
| 31 Dec 13 | 6,098 | 168 | 429 | 144 |
Ingresos de calidad: AKE tiene ganancias de alta calidad.
Margen de beneficios creciente: Los actuales márgenes de beneficio(3.6%) de AKE son inferiores a los del año pasado (4%).
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: Los beneficios de AKE han disminuido en un 1.2% al año en los últimos 5 años.
Acelerando crecimiento: AKE ha tenido un crecimiento negativo de los beneficios en el último año, por lo que no puede compararse con su media de 5 años.
Beneficios vs. Industria: AKE tuvo un crecimiento negativo de los beneficios (-12%) durante el año pasado, lo que dificulta la comparación con la media de la industria Chemicals (-8.2%).
Rentabilidad financiera
Alta ROE: La rentabilidad financiera de AKE (5%) se considera baja.